Mirtazapine-Induced Thrombocytopenia and Neutropenia
Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 3
Abstract
To the Editor, Neutropenia is a rare and commonly reversible sideeffect of antidepressant treatment [1]. Mirtazapine is a noradrenergic and specific serotonergic antidepressant that is approved for use in the treatment of major depression in many countries [2]. A major hematological side effect of mirtazapine is agranulocytosis. Herein we report a patient with depression that developed severe neutropenia-associated thrombocytopenia during treatment with mirtazapine; the patient was safely treated by switching to another drug.
Authors and Affiliations
Selami Toprak, Elçin Erdogan, Özlem Azap
Keywords
Related Articles
- EP ID EP116634
- DOI 10.5505/tjh.2012.72325
- Views 64
- Downloads 0
A Novel Homozygous Nucleotide Deletion in the JAK2 Gene in a Pediatric Patient with B-cell Precursor Acute Lymphoblastic Leukemia
To the Editor, Janus kinase 2 (JAK2) is a protein tyrosine kinase that transduces cellular signals through the Janus kinase signal transducer and an activator of transcription pathways (JAK-STAT), which mediates c...
Severe Adenovirus Infection Associated with Hemophagocytic Lymphohistiocytosis
Nitric oxide in beta-thalassemia minor: what factors contribute?
The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation
Chediak-Higashi syndrome is a rare autosomal recessive disease that was first described in 1943 by Bequez-Cesar in 3 siblings that bore the primary clinical features. In 1952 Chediak (a Cuban hematologist) and in 1954 Hi...
İntravenöz Siklosporin ile Anafilaksiye Giren ve Oral Formu Tolere Eden Bir Pediatrik Olgu